RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: substance-induced psychosis
Accession: DOID:8646
browse the term
Definition: Psychotic organic mental disorders resulting from the toxic effect of drugs and chemicals or other harmful substance.
Synonyms: exact_synonym: Drug Psychoses; Toxic Psychoses; substance-induced psychoses
primary_id: MESH:D011605 ; RDO:0006434
xref: ICD9CM:293.89
For additional species annotation, visit the
Alliance of Genome Resources .
GViewer not supported for the selected species.
G
Ace
angiotensin I converting enzyme
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17196621
NCBI chrNW_004624849:998,262...1,019,305
Ensembl chrNW_004624849:998,277...1,019,521
G
Adora2a
adenosine A2a receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20799992
NCBI chrNW_004624747:9,846,254...9,860,938
Ensembl chrNW_004624747:9,851,153...9,860,094
G
Akt1
AKT serine/threonine kinase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21041608
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
G
Camk2b
calcium/calmodulin dependent protein kinase II beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17603807
NCBI chrNW_004624740:7,750,327...7,828,891
Ensembl chrNW_004624740:7,750,245...7,831,454
G
Esr1
estrogen receptor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19386276
NCBI chrNW_004624785:6,164,507...6,601,302
Ensembl chrNW_004624785:6,164,379...6,601,326
G
Grm2
glutamate metabotropic receptor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20211215
NCBI chrNW_004624730:5,419,892...5,431,268
Ensembl chrNW_004624730:5,419,896...5,431,361
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19747927
NCBI chrNW_004624815:5,817,196...5,821,197
Ensembl chrNW_004624815:5,816,601...5,820,864
G
Htr6
5-hydroxytryptamine receptor 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20705401
NCBI chrNW_004624764:4,778,563...4,791,505
Ensembl chrNW_004624764:4,778,657...4,791,458
G
Npy1r
neuropeptide Y receptor Y1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19566775
NCBI chrNW_004624758:13,542,467...13,545,106
Ensembl chrNW_004624758:13,536,493...13,545,599
G
Oprm1
opioid receptor mu 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16402083
NCBI chrNW_004624785:4,147,079...4,195,712
Ensembl chrNW_004624785:4,032,689...4,196,186
G
Phb1
prohibitin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:18504422
NCBI chrNW_004624795:5,556,728...5,565,969
Ensembl chrNW_004624795:5,556,450...5,565,988
G
Pick1
protein interacting with PRKCA 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17606663
NCBI chrNW_004624752:9,880,773...9,895,270
Ensembl chrNW_004624752:9,880,670...9,895,230
G
Rgs9
regulator of G protein signaling 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17318883
NCBI chrNW_004624870:3,138,311...3,249,297
Ensembl chrNW_004624870:3,143,950...3,218,117
G
Slc6a3
solute carrier family 6 member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:12931138
NCBI chrNW_004624751:694,165...720,287
Ensembl chrNW_004624751:694,099...719,465
G
Snca
synuclein alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15542733
NCBI chrNW_004624757:17,393,046...17,528,783
Ensembl chrNW_004624757:17,392,998...17,528,320
G
Sod2
superoxide dismutase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16807759
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
G
Aldh2
aldehyde dehydrogenase 2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26711020
NCBI chrNW_004624747:20,407,190...20,438,605
Ensembl chrNW_004624747:20,403,717...20,438,690
G
Ankk1
ankyrin repeat and kinase domain containing 1
ISO
DNA:SNP:exon:rs1800497(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004624784:8,810,409...8,821,732
Ensembl chrNW_004624784:8,810,559...8,820,444
G
Drd2
dopamine receptor D2
ISO
DNA:SNP:cds:957C>T(human)
RGD
PMID:18669994
RGD:401959336
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
Foxo4
forkhead box O4
ISO
protein:increased phosphorylation:small intestine:
RGD
PMID:23292333
RGD:10402360
NCBI chrNW_004624903:1,390,899...1,399,745
Ensembl chrNW_004624903:1,391,910...1,399,949
G
Gsr
glutathione-disulfide reductase
treatment
ISO
RGD
PMID:24972622
RGD:10401897
NCBI chrNW_004624780:13,440,269...13,497,435
Ensembl chrNW_004624780:13,440,235...13,496,535
G
Hectd4
HECT domain E3 ubiquitin protein ligase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35713687
NCBI chrNW_004624747:19,843,434...20,031,188
Ensembl chrNW_004624747:19,843,720...20,029,225
G
Ank3
ankyrin 3
ISO
DNA:SNP:CDS:rs7917190
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004624791:3,299,287...3,633,631
G
Arhgef10
Rho guanine nucleotide exchange factor 10
ISO
associated with cleft lip; DNA:SNP: :rs2294035, rs4876274
RGD
PMID:31372216
RGD:597830081
NCBI chrNW_004624861:992,824...1,083,048
Ensembl chrNW_004624861:1,006,948...1,082,106
G
Rps6ka1
ribosomal protein S6 kinase A1
ISO
DNA:SNP:CDS:rs4659444
RGD
PMID:29109170
RGD:597830079
NCBI chrNW_004624764:10,527,012...10,566,625
Ensembl chrNW_004624764:10,526,948...10,569,910
G
Htr2a
5-hydroxytryptamine receptor 2A
ISO
DNA:SNP:promoter:-1438G>A
RGD
PMID:11842624
RGD:401900738
NCBI chrNW_004624748:8,154,288...8,223,226
Ensembl chrNW_004624748:8,155,107...8,223,259
G
Arrb2
arrestin beta 2
ISO
protein:increased expression:striatum
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004624786:8,568,102...8,576,445
Ensembl chrNW_004624786:8,568,198...8,577,914
G
Drd2
dopamine receptor D2
ISO
RGD
PMID:26174132
RGD:11534754
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
Gad1
glutamate decarboxylase 1
susceptibility
ISO
protein:decreased expression:prefrontal cortex associated with amphetamine abuse; DNA:haplotype: :rs769404���rs701492(human)
RGD
PMID:24200867 PMID:27967329
RGD:401900122 RGD:401900162
NCBI chrNW_004624787:8,308,759...8,345,929
Ensembl chrNW_004624787:8,308,759...8,347,686
G
Gad2
glutamate decarboxylase 2
susceptibility
ISO
associated with amphetamine abuse; DNA:SNP: :rs2236418(human)
RGD
PMID:27967329
RGD:401900122
NCBI chrNW_004624796:2,700,443...2,771,757
Ensembl chrNW_004624796:2,703,614...2,771,555
G
Oprm1
opioid receptor mu 1
ISO
associated with amphetamine abuse;DNA:SNP:intron:IVS2+691G>C (human)
RGD
PMID:16402083
RGD:401827939
NCBI chrNW_004624785:4,147,079...4,195,712
Ensembl chrNW_004624785:4,032,689...4,196,186
G
Ank3
ankyrin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004624791:3,299,287...3,633,631
G
Apoe
apolipoprotein E
ISO
RGD
PMID:15007105
RGD:12904641
NCBI chrNW_004624907:1,752,322...1,755,308
G
Avp
arginine vasopressin
ISO
mRNA:decreased expression:hypothalamic nucleus
RGD
PMID:15142835
RGD:596933086
NCBI chrNW_004624741:4,208,305...4,210,097
Ensembl chrNW_004624741:4,208,329...4,210,071
G
Bpifa1
BPI fold containing family A member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15513904
NCBI chrNW_004624842:6,024,460...6,031,718
G
C3
complement C3
ISO
protein:increased activity:blood
RGD
PMID:30657461
RGD:408418720
NCBI chrNW_004624828:3,773,816...3,798,077
Ensembl chrNW_004624828:3,770,221...3,797,946
G
Cat
catalase
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:26074427
NCBI chrNW_004624767:12,680,940...12,715,468
Ensembl chrNW_004624767:12,680,953...12,715,739
G
Crhr1
corticotropin releasing hormone receptor 1
sexual_dimorphism
ISO
associated with chronic mild stress, age effect; mRNA:altered expression:hippocampus (rat)
RGD
PMID:29251811
RGD:401965484
NCBI chrNW_004624849:2,484,144...2,528,130
Ensembl chrNW_004624849:2,484,109...2,528,223
G
Dio3
iodothyronine deiodinase 3
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624734:2,611,864...2,613,932
G
Dnmt1
DNA methyltransferase 1
ISO
mRNA,protein:increased expression:Pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624828:2,316,042...2,358,866
Ensembl chrNW_004624828:2,315,251...2,358,711
G
Dnmt3b
DNA methyltransferase 3 beta
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624842:6,450,972...6,505,929
Ensembl chrNW_004624842:6,450,852...6,475,785
G
Drd2
dopamine receptor D2
ISO
DNA:Hypermethylation:promoter mRNA:decreased expression: pituitary gland (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004624784:8,828,589...8,906,617
Ensembl chrNW_004624784:8,827,006...8,865,529
G
Ehmt2
euchromatic histone lysine methyltransferase 2
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624754:24,354,271...24,368,319
Ensembl chrNW_004624754:24,354,284...24,368,638
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta3
treatment sexual_dimorphism
ISO
in male mice only; mRNA:increased expression:frontal cortex:
RGD
PMID:23763370 PMID:30312858
RGD:13432044 RGD:405866345
NCBI chrNW_004624896:962,253...1,173,842
Ensembl chrNW_004624896:966,487...1,173,625
G
Gabrg2
gamma-aminobutyric acid type A receptor subunit gamma2
ISO
mRNA:increased expression:posterior hypothalamic region (rat)
RGD
PMID:18514412
RGD:402528884
NCBI chrNW_004624733:27,506,827...27,593,750
Ensembl chrNW_004624733:27,504,660...27,594,039
G
Grin2b
glutamate ionotropic receptor NMDA type subunit 2B
treatment
ISO
RGD
PMID:22037411 PMID:23763370
RGD:13210751 RGD:13432044
NCBI chrNW_004624752:24,008,520...24,480,834
Ensembl chrNW_004624752:24,135,487...24,459,288
G
Hdac2
histone deacetylase 2
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624856:4,834,197...4,861,546
Ensembl chrNW_004624856:4,834,217...4,861,592
G
Hdac4
histone deacetylase 4
ISO
mRNA,protein:increased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624847:3,846,196...4,101,537
Ensembl chrNW_004624847:3,845,858...4,101,487
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
ISO
protein:increased expression:placenta (rat)
RGD
PMID:26342748
RGD:401965481
NCBI chrNW_004624746:18,883,587...18,889,205
Ensembl chrNW_004624746:18,883,353...18,889,402
G
Igf1
insulin like growth factor 1
ISO
mRNA:decreased expression:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004624750:5,881,065...5,954,799
Ensembl chrNW_004624750:5,881,091...5,952,300
G
Igf1r
insulin like growth factor 1 receptor
ISO
protein:decreased activity:cerebellum (rat)
RGD
PMID:16909201
RGD:12904886
NCBI chrNW_004624768:5,396,027...5,688,435
Ensembl chrNW_004624768:5,396,156...5,681,809
G
Mat2a
methionine adenosyltransferase 2A
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624749:17,596,381...17,603,804
Ensembl chrNW_004624749:17,596,381...17,603,867
G
Mecp2
methyl-CpG binding protein 2
treatment
ISO
mRNA:increased expression:pituitary gland (rat)
RGD
PMID:23763370 PMID:26509893
RGD:11344152 RGD:13432044
NCBI chrNW_004624946:620,581...685,339
Ensembl chrNW_004624946:628,284...685,246
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624775:13,791,690...13,903,888
Ensembl chrNW_004624775:13,792,043...13,896,559
G
Nos1
nitric oxide synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25511929
NCBI chrNW_004624747:15,940,614...16,118,051
Ensembl chrNW_004624747:16,003,969...16,113,165
G
Oprk1
opioid receptor kappa 1
ISO
DNA, mRNA:hypomethylation, increased expression:ventral tegmental area, prefrontal cortex
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624735:2,301,248...2,325,678
Ensembl chrNW_004624735:2,301,101...2,325,684
G
Oprl1
opioid related nociceptin receptor 1
ISO
mRNA:decreased expression:ventral tegmental area
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624741:29,713,937...29,720,617
Ensembl chrNW_004624741:29,714,477...29,720,716
G
Pdyn
prodynorphin
ISO
DNA, mRNA:hypomethylation, altered expression:ventral tegmental area, nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624741:3,239,101...3,253,507
Ensembl chrNW_004624741:3,237,942...3,253,503
G
Per2
period circadian regulator 2
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004624847:3,359,174...3,399,584
Ensembl chrNW_004624847:3,361,170...3,390,405
G
Pnoc
prepronociceptin
ISO
mRNA:increased expression:nucleus accumbens
RGD
PMID:29678771
RGD:401851055
NCBI chrNW_004624758:23,007,530...23,026,962
Ensembl chrNW_004624758:23,007,573...23,028,704
G
Pomc
proopiomelanocortin
treatment
ISO
RGD
PMID:31329297
RGD:405878078
NCBI chrNW_004624738:7,442,223...7,448,513
Ensembl chrNW_004624738:7,442,292...7,445,020
G
Prl
prolactin
ISO
mRNA,protein:increased expression:pituitary gland, blood plasma (rat) mRNA, protein:increased expression:pituitary gland, blood plasma (rat)
RGD
PMID:26509893 PMID:28710248
RGD:11344152 RGD:401960105
NCBI chrNW_004624756:4,585,542...4,593,285
G
Pten
phosphatase and tensin homolog
ISO
Protein:increased expression, increased activity:cerebellum (rat)
RGD
PMID:12700235
RGD:12801493
NCBI chrNW_004624791:13,975,235...14,056,900
G
Rasgrf1
Ras protein specific guanine nucleotide releasing factor 1
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624941:110,752...222,143
Ensembl chrNW_004624941:110,676...222,092
G
Rps6ka1
ribosomal protein S6 kinase A1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29109170
NCBI chrNW_004624764:10,527,012...10,566,625
Ensembl chrNW_004624764:10,526,948...10,569,910
G
Setd7
SET domain containing 7, histone lysine methyltransferase
ISO
mRNA:decreased expression:pituitary gland (rat)
RGD
PMID:26509893
RGD:11344152
NCBI chrNW_004624777:19,764,383...19,812,804
Ensembl chrNW_004624777:19,768,698...19,814,506
G
Slc25a12
solute carrier family 25 member 12
treatment
ISO
RGD
PMID:23763370
RGD:13432044
NCBI chrNW_004624787:9,187,450...9,319,684
Ensembl chrNW_004624787:9,184,514...9,320,060
G
Slc6a4
solute carrier family 6 member 4
ISO
mRNA:decreased expression:brain (rat)
RGD
PMID:26180184
RGD:11074449
NCBI chrNW_004624786:2,673,285...2,711,432
Ensembl chrNW_004624786:2,672,552...2,710,914
G
Tlr4
toll like receptor 4
ameliorates
ISO
RGD
PMID:30312858
RGD:405866345
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
Rhoa
ras homolog family member A
ISO
protein:increased activation:neuron, cerebellum
RGD
PMID:17109064
RGD:2298867
NCBI chrNW_004624730:3,316,122...3,361,820
G
Ager
advanced glycosylation end-product specific receptor
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004624754:24,138,086...24,140,900
G
Agtr1
angiotensin II receptor type 1
ISO
RGD
PMID:24814703
RGD:10047100
NCBI chrNW_004624730:25,964,848...26,006,468
Ensembl chrNW_004624730:25,964,811...26,006,463
G
Akt1
AKT serine/threonine kinase 1
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004624734:507,880...525,295
Ensembl chrNW_004624734:509,368...525,295
G
App
amyloid beta precursor protein
treatment
ISO
protein:increased expression:plasma protein:increased expression:hippocampus
RGD
PMID:30221701 PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178 RGD:597931096
NCBI chrNW_004624745:13,904,912...14,159,374
Ensembl chrNW_004624745:13,902,577...14,159,372
G
Bace1
beta-secretase 1
treatment
ISO
RGD
PMID:30221701 PMID:33574912
RGD:597830178 RGD:597931096
NCBI chrNW_004624784:12,725,419...12,759,530
Ensembl chrNW_004624784:12,725,063...12,759,637
G
Bax
BCL2 associated X, apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004624832:5,050,222...5,068,565
Ensembl chrNW_004624832:5,050,222...5,055,506
G
Bcl2
BCL2 apoptosis regulator
treatment
ISO
RGD
PMID:33574912
RGD:597830178
NCBI chrNW_004624792:8,854,345...9,032,727
Ensembl chrNW_004624792:8,859,522...9,031,344
G
Bdnf
brain derived neurotrophic factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29065194 PMID:29571823 PMID:29599834 PMID:30232930 PMID:32564283 PMID:33324197 PMID:34964700 More...
RGD:401959211 RGD:401965400 RGD:401976548 RGD:405850212 RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004624766:17,281,882...17,330,601
Ensembl chrNW_004624766:17,279,630...17,330,490
G
Creb1
cAMP responsive element binding protein 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:29571823 PMID:36688960 PMID:37736695
RGD:401959211 RGD:401959611 RGD:401960090
NCBI chrNW_004624765:8,374,160...8,436,969
G
Gdnf
glial cell derived neurotrophic factor
treatment
ISO
protein:decreased expression:hippocampus,urine associated with rheumatic heart disease;protein:increased expression:serum protein:altered expression:hippocampus, urine
RGD
PMID:25251457 PMID:28918204 PMID:29512789 PMID:33324197 PMID:34728231 PMID:36688960 More...
RGD:401959611 RGD:405849389 RGD:405850212 RGD:405850250 RGD:405850251 RGD:405866364
NCBI chrNW_004624759:17,263,570...17,290,046
Ensembl chrNW_004624759:17,263,969...17,287,723
G
Hmgb1
high mobility group box 1
ISO
mRNA, protein:increased expression:hippocampus
RGD
PMID:23078219
RGD:597805826
NCBI chrNW_004624776:7,858,400...7,862,716
Ensembl chrNW_004624776:7,793,259...7,863,184
G
Igf1
insulin like growth factor 1
treatment
ISO
mRNA:decreased expression:hippocampus mRNA:decreased expression:plasma
RGD
PMID:33574912 PMID:35317728
RGD:597830151 RGD:597830178
NCBI chrNW_004624750:5,881,065...5,954,799
Ensembl chrNW_004624750:5,881,091...5,952,300
G
Igfbp7
insulin like growth factor binding protein 7
ISO
protein:increased expression:plasma (human)
RGD
PMID:25543030
RGD:401960875
NCBI chrNW_004624761:12,318,571...12,387,489
Ensembl chrNW_004624761:12,318,006...12,387,582
G
Il1b
interleukin 1 beta
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:22959208 PMID:23078219 PMID:29571823 PMID:30221701 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826 RGD:597931096 RGD:7204702
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
G
Il1rn
interleukin 1 receptor antagonist
treatment
ISO
human protein in a rat model
RGD
PMID:23077050
RGD:8551854
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
G
Il6
interleukin 6
treatment
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:28684969 PMID:30221701 PMID:33390808
RGD:401965467 RGD:597538492 RGD:597931096
NCBI chrNW_004624739:7,957,709...7,963,414
Ensembl chrNW_004624739:7,957,674...7,962,318
G
Ireb2
iron responsive element binding protein 2
ISO
protein:increased expression:hippocampus (rat)
RGD
PMID:23229539
RGD:12904023
NCBI chrNW_004624894:2,446,014...2,498,650
Ensembl chrNW_004624894:2,445,704...2,499,009
G
Mapk1
mitogen-activated protein kinase 1
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004624747:1,296,062...1,389,674
Ensembl chrNW_004624747:1,296,221...1,389,757
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
protein:decreased phosphorylation:hippocampus
RGD
PMID:36688960 PMID:37736695
RGD:401959611 RGD:401960090
NCBI chrNW_004624782:13,150,824...13,158,327
Ensembl chrNW_004624782:13,152,039...13,159,113
G
Ngf
nerve growth factor
treatment
ISO
associated with brain ischemia
RGD
PMID:29599834 PMID:30481505 PMID:34964700
RGD:401965395 RGD:401965400 RGD:401976548
NCBI chrNW_004624772:11,009,765...11,070,050
Ensembl chrNW_004624772:11,010,845...11,070,017
G
Nr3c1
nuclear receptor subfamily 3 group C member 1
treatment
ISO
associated with Traumatic Brain Injuries;mRNA:decreased expression:hippocampus, hypothalamus
RGD
PMID:28086911 PMID:36637480
RGD:408345237 RGD:408364984
NCBI chrNW_004624774:2,496,276...2,603,894
Ensembl chrNW_004624774:2,495,304...2,602,632
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
treatment
ISO
RGD
PMID:29065194 PMID:30232930 PMID:32564283
RGD:596933096 RGD:596936243 RGD:596936414
NCBI chrNW_004624809:8,274,736...8,622,287
Ensembl chrNW_004624809:8,276,951...8,616,765
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
treatment
ISO
RGD
PMID:30221701
RGD:597931096
NCBI chrNW_004624730:15,226,786...15,399,097
Ensembl chrNW_004624730:15,226,379...15,355,857
G
Tlr2
toll like receptor 2
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004624858:4,931,820...4,984,175
Ensembl chrNW_004624858:4,979,485...4,981,833
G
Tlr4
toll like receptor 4
treatment
ISO
RGD
PMID:28684969 PMID:32300366
RGD:597538486 RGD:597538492
NCBI chrNW_004624760:17,596,516...17,608,955
Ensembl chrNW_004624760:17,598,630...17,609,120
G
Tnf
tumor necrosis factor
treatment
ISO
mRNA, protein:increased expression:hippocampus protein:increased expression:hippocampus (rat)
RGD
PMID:23078219 PMID:29571823 PMID:33390808
RGD:401959211 RGD:401965467 RGD:597805826
NCBI chrNW_004624754:24,623,059...24,625,647
Ensembl chrNW_004624754:24,623,425...24,625,531
G
Ache
acetylcholinesterase (Cartwright blood group)
disease_progression
ISO
RGD
PMID:8043620
RGD:405855847
NCBI chrNW_004624740:16,275,108...16,280,639
Ensembl chrNW_004624740:16,275,117...16,281,793
G
Htr1a
5-hydroxytryptamine receptor 1A
ISO
mRNA, protein:increased expression:hippocampal formation, amygdala
RGD
PMID:27760517
RGD:405850209
NCBI chrNW_004624815:5,817,196...5,821,197
Ensembl chrNW_004624815:5,816,601...5,820,864
G
Tph2
tryptophan hydroxylase 2
ISO
mRNA:increased expression:hippocampus, prefrontal cortex
RGD
PMID:36750928
RGD:597805905
NCBI chrNW_004624750:25,702,597...25,801,938
Ensembl chrNW_004624750:25,702,630...25,801,618
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all